JAKARTA - Dry eye disease (dry eye disease) is one of the most complained about eye health disorders today, with symptoms ranging from dryness, pain, to blurred vision that can affect comfort and daily quality of life.
A retrospective study of 159 dry eye patients conducted by Lemp MA and colleagues, and published in the journal Cornea, showed that about 50 percent of patients suffer from Evaporative Dry Eye, 36 percent have Mixed Dry Eye, and 14 percent have Aqueous Deficient Dry Eye. These findings indicate that the majority of dry eye patients require a therapeutic approach that not only adds moisture, but also helps maintain the stability of the tear film as a whole.
This condition is becoming increasingly relevant in the Asian region, given that the prevalence of Meibomian Gland Dysfunction (MGD), one of the main causes of evaporative dry eye, is reported to be higher than in other regions, ranging from 46 to 70 percent. Environmental factors such as temperature, air humidity levels, and air quality also contribute to the high number of dry eye cases in this region.
"Based on the study we conducted, currently dry eye symptoms are experienced by about three out of four patients who come to consult a doctor. Based on these findings, we developed this product to help medical personnel handle various dry eye symptoms more comprehensively," said Patcharin Charmnoot, Alcon SEA Cluster Head, in a statement. , Monday, February 9.
Responding to this need, PT Anugrah Argon Medica (AAM), a subsidiary of PT Medela Potentia Tbk (MDLA), together with Alcon officially launched Systane® Complete Multi-Dose Preservative-Free, an innovative eye drop from Alcon designed as a complete solution for the entire spectrum of dry eyes, first in Indonesia, on Sunday, February 1, 2026, at The Ritz-Carlton Jakarta.
The launch was attended by the President Director of PT Medela Potentia Tbk Krestijanto Pandji; President Director of PT Anugrah Argon Medica Juliwaty; Commercial Director AAM Budi Lim; Alcon SEA Cluster Head Patcharin Charmnoot; Chairman of the Indonesian Ocular Infection & Immunology Society (INOIIS) PERDAMI Prof. Dr. dr. Ratna Sitompul, Sp.M(K); and PERDAMI Jaya Chairman dr. Julie Dewi Barliana, Sp.M(K), M.Biomed. The event was also attended by around 100 ophthalmologists, especially subspecialists in cornea and dry eye, from various leading hospitals and eye clinics in Indonesia.
At this launch, a symposium on Complete Lipid Layer Restoration was also held with three speaker discussions, namely Lipid Layer Deficiency and Tear Evaporation: Rethinking the Pathophysiology of MGD-Related Dry Eye by dr. Rifna Luftiamida, Sp.M (K); The Role of Topical Combination of hydroxypropyl guar (HP-Guar) and nano-sized lipid droplets in Lipid Layer Changes of Dry Eye Diseases by dr. Yulia Aziza, Sp.M(K), PhD; and Complete Lipid Layer Restoration: Hands-On Clinical Experience Using HP-Guar and Nano-Sized Lipid Droplet Technology by Dr. Nina Asrini Noor, Sp.M.
The launch of Systane® Complete Multi-Dose Preservative-Free marks a strategic collaboration between Alcon, AAM, and INOIIS PERDAMI, as mineral oil-based artificial tears are not yet available in Indonesia specifically to treat evaporative dry eye due to MGD.
"At this moment, we are proud to present Systane® Complete Multi-Dose Preservative-Free as a product with a multidose package without preservatives. We hope that the presence of this product can be a good choice in helping to treat dry eyes, especially in patients with evaporative dry eye and MGD," said Juliwaty, President Director of PT Anugrah Argon Medica.
MGD is a condition when the function of the meibomian gland is disrupted so that the lipid layer in the tears is not optimally formed. As a result, the evaporation of tears occurs faster and causes various complaints of dry eyes.
In response to this, Prof. Dr. Ratna Sitompul, Sp.M(K) assessed the presence of eye drop therapy that supports the treatment of MGD as an important development in clinical practice in Indonesia.
"Today we see new ease in the treatment of MGD through eye drops. This is a good opportunity for medical personnel to provide more appropriate therapy according to patient needs," he said.
Systane® Complete Multi-Dose Preservative-Free is an eye drop that can be used for the entire spectrum of dry eyes, from evaporative dry eye due to lipid layer disorders, aqueous deficient dry eye due to lack of aqueous layer, to mixed dry eye. This product works by supporting the entire tear layer, including the lipid layer, so as to help maintain the stability of the tear film and relieve various symptoms of dry eyes comprehensively.
This product carries nano-sized lipid droplets technology combined with Hydroxypropyl Guar (HP-Guar), which has been clinically proven to provide multi-symptom relief for dry eye patients. In addition, Systane® Complete Multi-Dose Preservative-Free uses PureFlow® Technology, a preservative-free multidose bottle with a one-way valve designed to prevent contamination and make it easier to use, first in Indonesia.
"With the technology possessed by Systane® Complete Multi-Dose Preservative-Free, one drop can spread more optimally on the surface of the eye. In addition, the preservative-free multidose formulation is expected to help medical personnel and patients in dealing with dry eye problems more effectively," concluded Patcharin Charmnoot.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
